1. Home
  2. ACXP vs AQB Comparison

ACXP vs AQB Comparison

Compare ACXP & AQB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACXP
  • AQB
  • Stock Information
  • Founded
  • ACXP 2017
  • AQB 1991
  • Country
  • ACXP United States
  • AQB United States
  • Employees
  • ACXP N/A
  • AQB N/A
  • Industry
  • ACXP Biotechnology: Pharmaceutical Preparations
  • AQB
  • Sector
  • ACXP Health Care
  • AQB
  • Exchange
  • ACXP Nasdaq
  • AQB Nasdaq
  • Market Cap
  • ACXP 6.8M
  • AQB 7.1M
  • IPO Year
  • ACXP 2021
  • AQB N/A
  • Fundamental
  • Price
  • ACXP $4.24
  • AQB $2.07
  • Analyst Decision
  • ACXP Strong Buy
  • AQB
  • Analyst Count
  • ACXP 3
  • AQB 0
  • Target Price
  • ACXP $143.67
  • AQB N/A
  • AVG Volume (30 Days)
  • ACXP 89.0K
  • AQB 2.3M
  • Earning Date
  • ACXP 11-12-2025
  • AQB 11-04-2025
  • Dividend Yield
  • ACXP N/A
  • AQB N/A
  • EPS Growth
  • ACXP N/A
  • AQB N/A
  • EPS
  • ACXP N/A
  • AQB N/A
  • Revenue
  • ACXP N/A
  • AQB N/A
  • Revenue This Year
  • ACXP N/A
  • AQB N/A
  • Revenue Next Year
  • ACXP N/A
  • AQB N/A
  • P/E Ratio
  • ACXP N/A
  • AQB N/A
  • Revenue Growth
  • ACXP N/A
  • AQB N/A
  • 52 Week Low
  • ACXP $3.80
  • AQB $0.47
  • 52 Week High
  • ACXP $43.20
  • AQB $2.95
  • Technical
  • Relative Strength Index (RSI)
  • ACXP 51.39
  • AQB 59.44
  • Support Level
  • ACXP $3.97
  • AQB $1.79
  • Resistance Level
  • ACXP $4.85
  • AQB $2.95
  • Average True Range (ATR)
  • ACXP 0.35
  • AQB 0.32
  • MACD
  • ACXP -0.02
  • AQB 0.03
  • Stochastic Oscillator
  • ACXP 23.45
  • AQB 48.50

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

About AQB AquaBounty Technologies Inc.

AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.

Share on Social Networks: